Cite
Li H, Sisoudiya SD, Martin-Giacalone BA, et al. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Natl Cancer Inst. 2021;113(7):875-883doi: 10.1093/jnci/djaa204.
Li, H., Sisoudiya, S. D., Martin-Giacalone, B. A., Khayat, M. M., Dugan-Perez, S., Marquez-Do, D. A., Scheurer, M. E., Muzny, D., Boerwinkle, E., Gibbs, R. A., Chi, Y. Y., Barkauskas, D. A., Lo, T., Hall, D., Stewart, D. R., Schiffman, J. D., Skapek, S. X., Hawkins, D. S., Plon, S. E., Sabo, A., & Lupo, P. J. (2021). Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of the National Cancer Institute, 113(7), 875-883. https://doi.org/10.1093/jnci/djaa204
Li, He, et al. "Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group." Journal of the National Cancer Institute vol. 113,7 (2021): 875-883. doi: https://doi.org/10.1093/jnci/djaa204
Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, Scheurer ME, Muzny D, Boerwinkle E, Gibbs RA, Chi YY, Barkauskas DA, Lo T, Hall D, Stewart DR, Schiffman JD, Skapek SX, Hawkins DS, Plon SE, Sabo A, Lupo PJ. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Natl Cancer Inst. 2021 Jul 01;113(7):875-883. doi: 10.1093/jnci/djaa204. PMID: 33372952; PMCID: PMC8246828.
Copy
Download .nbib